Pharmaceutical Industry Research Report, Pharma Market

sale

Whole Cell Cholera Vaccine by End User

U

2026

Whole Cell Cholera Vaccine by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Cholera is a chronic disease associated with diarrhea and immediate treatment is essential as death is inevitable if the disease is left untreated. Cholera is an acute infection ...

Report Code : A03456 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Recombinant Chinese Hamster Ovary Cell (CHO) Hepatitis B...

U

2026

Recombinant Chinese Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...

Report Code : A03515 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Rhodamine B Market

U

2026

Rhodamine B Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Rhodamine B is a chemical compound that acts as a tracer dye, and assists to determine the rate as well as direction of flow and transport in water. ...

Report Code : A03516 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Amphotericin B Market

U

2026

Amphotericin B Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Amphotericin B is polyene class of drug and it is a subgroup of macrolide antibiotics. It works by interfering cell membrane of fungus. Amphotericin B is an antifungal drug which is used in treatment of critical fungal infections, leishmaniasis, and

Report Code : A13334 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Chronic Hepatitis B (CHB) Market

P

2022

Chronic Hepatitis B (CHB) Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global chronic hepatitis b (chb) market was valued at $4.6 billion in 2021, and is projected to reach $6.2 billion by 2031, growing at a CAGR of 3% from 2022 to 2031.

Report Code : A31523 | Pages : 290 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

North America Chronic Hepatitis B (CHB) Market

P

2023

North America Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

By component, the Drug Stores and Retail Pharmacies was the dominant sub-segment with major market share in 2021 in the North America Chronic Hepatitis B (CHB) Market. This sub-segment is likely to follow same momentum by the end of 2031.

Report Code : * A82313 | Pages : 109 | Category : Life Sciences

Price:

~~$2,850~~ $1,995 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

U.S. Chronic Hepatitis B (CHB) Market

P

2023

U.S. Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The U.S. Chronic Hepatitis B (CHB) Market is expected to expand at a promising compound annual growth rate (CAGR) between 2022 to 2031. The U.S. Chronic Hepatitis B (CHB) Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A82314 | Pages : 78 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Canada Chronic Hepatitis B (CHB) Market

P

2023

Canada Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Canada Chronic Hepatitis B (CHB) Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

Report Code : * A82315 | Pages : 87 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Mexico Chronic Hepatitis B (CHB) Market

P

2023

Mexico Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

Research study titled Mexico Chronic Hepatitis B (CHB) Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Report Code : * A82316 | Pages : 85 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Germany Chronic Hepatitis B (CHB) Market

P

2023

Germany Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

By end user, the Germany Chronic Hepatitis B (CHB) Market market is bifurcated into various sectors, Of those, Distribution Channel was the largest segment and captured considerable market share in 2021.

Report Code : * A82317 | Pages : 78 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

France Chronic Hepatitis B (CHB) Market

P

2023

France Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Distribution Channel in France Chronic Hepatitis B (CHB) Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A82318 | Pages : 80 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

UK Chronic Hepatitis B (CHB) Market

P

2023

UK Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The UK Chronic Hepatitis B (CHB) Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

Report Code : * A82319 | Pages : 75 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Italy Chronic Hepatitis B (CHB) Market

P

2023

Italy Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. Distribution Channel was the leading segment.

Report Code : * A82320 | Pages : 81 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Spain Chronic Hepatitis B (CHB) Market

P

2023

Spain Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

In market Distribution Channel, Drug Stores and Retail Pharmacies holds the largest revenue share during the analysis period and Distribution Channel is expected to exhibit the highest CAGR over the analysis period.

Report Code : * A82321 | Pages : 87 | Category : Life Sciences

Price:

~~$2,355~~ $1,649 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Australia Chronic Hepatitis B (CHB) Market

P

2023

Australia Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Distribution Channel in Australia Chronic Hepatitis B (CHB) Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

Report Code : * A82322 | Pages : 87 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Japan Chronic Hepatitis B (CHB) Market

P

2023

Japan Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Distribution Channel has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

Report Code : * A82323 | Pages : 84 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

China Chronic Hepatitis B (CHB) Market

P

2023

China Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Distribution Channel dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

Report Code : * A82324 | Pages : 74 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

South Korea Chronic Hepatitis B (CHB) Market

P

2023

South Korea Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

The South Korea Chronic Hepatitis B (CHB) Market achieved significant revenue share in base year of analysis. The South Korea Chronic Hepatitis B (CHB) Market size is expected to account for a considerable growth rate between 2022 to 2031.

Report Code : * A82325 | Pages : 85 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

India Chronic Hepatitis B (CHB) Market

P

2023

India Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

India Chronic Hepatitis B (CHB) Market is projected to experience high investment on various major technologies/product/services in India country by the end of 2031 owing to presence of key end user vertical adopting offerings at a faster pace.

Report Code : * A82326 | Pages : 81 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Saudi Arabia Chronic Hepatitis B (CHB) Market

P

2023

Saudi Arabia Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

Research study titled Saudi Arabia Chronic Hepatitis B (CHB) Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Report Code : * A82327 | Pages : 74 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Brazil Chronic Hepatitis B (CHB) Market

P

2023

Brazil Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

Brazil Chronic Hepatitis B (CHB) Market is projected to experience high investment on various major technologies/product/services in Brazil country by the end of 2031 owing to presence of key end user vertical adopting offerings at a faster pace.

Report Code : * A82328 | Pages : 78 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

South Africa Chronic Hepatitis B (CHB) Market

P

2023

South Africa Chronic Hepatitis B (CHB) Market: Opportunity Analysis and Industry Forecast, 2021-2031

Distribution Channel segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the South Africa Chronic Hepatitis B (CHB) Market due to the outbreak of COVID-19.

Report Code : * A82329 | Pages : 81 | Category : Life Sciences

Price:

~~$2,175~~ $1,523 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

Cholera is a chronic disease associated with diarrhea and immediate treatment is essential as death is inevitable if the disease is left untreated. Cholera is an acute infection ...

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...

Rhodamine B is a chemical compound that acts as a tracer dye, and assists to determine the rate as well as direction of flow and transport in water. ...

Amphotericin B is polyene class of drug and it is a subgroup of macrolide antibiotics. It works by interfering cell membrane of fungus. Amphotericin B is an antifungal drug which is used in treatment of critical fungal infections, leishmaniasis, and

The global chronic hepatitis b (chb) market was valued at $4.6 billion in 2021, and is projected to reach $6.2 billion by 2031, growing at a CAGR of 3% from 2022 to 2031.

By component, the Drug Stores and Retail Pharmacies was the dominant sub-segment with major market share in 2021 in the North America Chronic Hepatitis B (CHB) Market. This sub-segment is likely to follow same momentum by the end of 2031.

The U.S. Chronic Hepatitis B (CHB) Market is expected to expand at a promising compound annual growth rate (CAGR) between 2022 to 2031. The U.S. Chronic Hepatitis B (CHB) Market growth is attributed to various driving factors and revenue opportunities.

The Canada Chronic Hepatitis B (CHB) Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

Research study titled Mexico Chronic Hepatitis B (CHB) Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

By end user, the Germany Chronic Hepatitis B (CHB) Market market is bifurcated into various sectors, Of those, Distribution Channel was the largest segment and captured considerable market share in 2021.

The Distribution Channel in France Chronic Hepatitis B (CHB) Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

The UK Chronic Hepatitis B (CHB) Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. Distribution Channel was the leading segment.

In market Distribution Channel, Drug Stores and Retail Pharmacies holds the largest revenue share during the analysis period and Distribution Channel is expected to exhibit the highest CAGR over the analysis period.

The Distribution Channel in Australia Chronic Hepatitis B (CHB) Market generated the major share in terms of revenue in the base year analysis. The report analyses industry players and the strategies adopted by them

The Distribution Channel has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.

The Distribution Channel dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.

The South Korea Chronic Hepatitis B (CHB) Market achieved significant revenue share in base year of analysis. The South Korea Chronic Hepatitis B (CHB) Market size is expected to account for a considerable growth rate between 2022 to 2031.

India Chronic Hepatitis B (CHB) Market is projected to experience high investment on various major technologies/product/services in India country by the end of 2031 owing to presence of key end user vertical adopting offerings at a faster pace.

Research study titled Saudi Arabia Chronic Hepatitis B (CHB) Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Brazil Chronic Hepatitis B (CHB) Market is projected to experience high investment on various major technologies/product/services in Brazil country by the end of 2031 owing to presence of key end user vertical adopting offerings at a faster pace.

Distribution Channel segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the South Africa Chronic Hepatitis B (CHB) Market due to the outbreak of COVID-19.